195 related articles for article (PubMed ID: 32660552)
1. Combined therapy with ceftriaxone and doxycycline does not improve the outcome of meningococcal meningitis in mice compared to ceftriaxone monotherapy.
Ricci S; Grandgirard D; Masouris I; Braccini T; Pozzi G; Oggioni MR; Koedel U; Leib SL
BMC Infect Dis; 2020 Jul; 20(1):505. PubMed ID: 32660552
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of matrix metalloproteinases attenuates brain damage in experimental meningococcal meningitis.
Ricci S; Grandgirard D; Wenzel M; Braccini T; Salvatore P; Oggioni MR; Leib SL; Koedel U
BMC Infect Dis; 2014 Dec; 14():726. PubMed ID: 25551808
[TBL] [Abstract][Full Text] [Related]
3. Combined effect of non-bacteriolytic antibiotic and inhibition of matrix metalloproteinases prevents brain injury and preserves learning, memory and hearing function in experimental paediatric pneumococcal meningitis.
Muri L; Grandgirard D; Buri M; Perny M; Leib SL
J Neuroinflammation; 2018 Aug; 15(1):233. PubMed ID: 30131074
[TBL] [Abstract][Full Text] [Related]
4. Combining Ceftriaxone with Doxycycline and Daptomycin Reduces Mortality, Neuroinflammation, Brain Damage, and Hearing Loss in Infant Rat Pneumococcal Meningitis.
Muri L; Perny M; Zemp J; Grandgirard D; Leib SL
Antimicrob Agents Chemother; 2019 Jul; 63(7):. PubMed ID: 31061158
[TBL] [Abstract][Full Text] [Related]
5. Metformin mediates neuroprotection and attenuates hearing loss in experimental pneumococcal meningitis.
Muri L; Le ND; Zemp J; Grandgirard D; Leib SL
J Neuroinflammation; 2019 Jul; 16(1):156. PubMed ID: 31351490
[TBL] [Abstract][Full Text] [Related]
6. Randomized controlled trial of the relative efficacy of high-dose intravenous ceftriaxone and oral cefixime combined with doxycycline for the treatment of Chlamydia trachomatis and Neisseria gonorrhoeae co-infection.
Nguyen PTT; Pham HV; Van DH; Pham LV; Nguyen HT; Nguyen HV
BMC Infect Dis; 2022 Jul; 22(1):607. PubMed ID: 35810277
[TBL] [Abstract][Full Text] [Related]
7. Ceftriaxone as effective as long-acting chloramphenicol in short-course treatment of meningococcal meningitis during epidemics: a randomised non-inferiority study.
Nathan N; Borel T; Djibo A; Evans D; Djibo S; Corty JF; Guillerm M; Alberti KP; Pinoges L; Guerin PJ; Legros D
Lancet; 2005 Jul 23-29; 366(9482):308-13. PubMed ID: 16039333
[TBL] [Abstract][Full Text] [Related]
8. Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis.
Grandgirard D; Schürch C; Cottagnoud P; Leib SL
Antimicrob Agents Chemother; 2007 Jun; 51(6):2173-8. PubMed ID: 17371820
[TBL] [Abstract][Full Text] [Related]
9. Rifampicin+ceftriaxone versus vancomycin+ceftriaxone in the treatment of penicillin- and cephalosporin-resistant pneumococcal meningitis in an experimental rabbit model.
Suntur BM; Yurtseven T; Sipahi OR; Buke C; Buke M
Int J Antimicrob Agents; 2005 Sep; 26(3):258-60. PubMed ID: 16099624
[TBL] [Abstract][Full Text] [Related]
10. [Meningococcemia and meningitis due to Neisseria meningitidis W135 developed in two cases vaccinated with bivalent (A/C) meningococcal vaccine].
Turhan V; Acar A; Kılıç A; Budak S; Oncül O; Haznedaroğlu T; Görenek L
Mikrobiyol Bul; 2010 Jul; 44(3):473-8. PubMed ID: 21063998
[TBL] [Abstract][Full Text] [Related]
11. Adjunctive daptomycin attenuates brain damage and hearing loss more efficiently than rifampin in infant rat pneumococcal meningitis.
Grandgirard D; Burri M; Agyeman P; Leib SL
Antimicrob Agents Chemother; 2012 Aug; 56(8):4289-95. PubMed ID: 22644021
[TBL] [Abstract][Full Text] [Related]
12. Cefotaxime and ceftriaxone cerebrospinal fluid levels during treatment of bacterial meningitis in children.
Goldwater PN
Int J Antimicrob Agents; 2005 Nov; 26(5):408-11. PubMed ID: 16216469
[TBL] [Abstract][Full Text] [Related]
13. Ceftriaxone alone compared to ampicillin and chloramphenicol in the treatment of bacterial meningitis.
Girgis NI; Abu el-Ella AH; Farid Z; Haberberger RL; Woody JN
Chemotherapy; 1988; 34 Suppl 1():16-20. PubMed ID: 3246167
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant glycerol is not beneficial in experimental pneumococcal meningitis.
Blaser C; Klein M; Grandgirard D; Wittwer M; Peltola H; Weigand M; Koedel U; Leib SL
BMC Infect Dis; 2010 Mar; 10():84. PubMed ID: 20353584
[TBL] [Abstract][Full Text] [Related]
15. Rifampin followed by ceftriaxone for experimental meningitis decreases lipoteichoic acid concentrations in cerebrospinal fluid and reduces neuronal damage in comparison to ceftriaxone alone.
Gerber J; Pohl K; Sander V; Bunkowski S; Nau R
Antimicrob Agents Chemother; 2003 Apr; 47(4):1313-7. PubMed ID: 12654664
[TBL] [Abstract][Full Text] [Related]
16. Virulence Traits of a Serogroup C Meningococcus and Isogenic
Colicchio R; Pagliuca C; Ricci S; Scaglione E; Grandgirard D; Masouris I; Farina F; Pagliarulo C; Mantova G; Paragliola L; Leib SL; Koedel U; Pozzi G; Alifano P; Salvatore P
Infect Immun; 2019 Apr; 87(4):. PubMed ID: 30718288
[TBL] [Abstract][Full Text] [Related]
17. Bacterial meningitis in children in southern Ghana.
Commey JO; Rodrigues OP; Akita FA; Newman M
East Afr Med J; 1994 Feb; 71(2):113-7. PubMed ID: 7925039
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of GM6001 as an adjuvant to ceftriaxone in a neonatal rat model of Streptococcus pneumoniae meningitis.
Liu X; Han Q
Acta Neurobiol Exp (Wars); 2014; 74(4):489-96. PubMed ID: 25576979
[TBL] [Abstract][Full Text] [Related]
19. [Paediatric meningococcal meningitis in France: ACTIV/GPIP network results].
Levy C; Taha MK; Bingen E; Cohen R;
Arch Pediatr; 2012 Sep; 19 Suppl 2():S49-54. PubMed ID: 22883366
[TBL] [Abstract][Full Text] [Related]
20. An unusual case of chronic meningitis.
Boos C; Daneshvar C; Hinton A; Dawes M
BMC Fam Pract; 2004 Oct; 5():21. PubMed ID: 15469610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
